Clinical Trial Update: Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study comparing hydroxyurea alone versus hydroxyurea with aspirin in essential thrombocythemia; the trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Myeloproliferative Neoplasms

Drugs mentioned

• Aspirin (Aspirin)
• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: MPN, Essential Thrombocythemia | Phase 3 | Status: UNKNOWN